Prognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis

[1]  M. Hashizume,et al.  CD146 attenuation in cancer‐associated fibroblasts promotes pancreatic cancer progression , 2016, Molecular carcinogenesis.

[2]  Xuehao Wang,et al.  CD146 promotes metastasis and predicts poor prognosis of hepatocellular carcinoma , 2016, Journal of experimental & clinical cancer research : CR.

[3]  M. Zheng,et al.  CD146 as an adverse prognostic factor in uterine sarcoma , 2015, European Journal of Medical Research.

[4]  Huang Wang,et al.  The multifaceted role of CD146/MCAM in the promotion of melanoma progression , 2015, Cancer Cell International.

[5]  E. Dickerson,et al.  Frequent and increased expression of human METCAM/MUC18 in cancer tissues and metastatic lesions is associated with the clinical progression of human ovarian carcinoma. , 2014, Taiwanese journal of obstetrics & gynecology.

[6]  Li-Li Liu,et al.  Correlation of CD146 expression and clinicopathological characteristics in esophageal squamous cell carcinoma , 2014, Oncology letters.

[7]  Z. Wang,et al.  MCAM expression is associated with poor prognosis in non-small cell lung cancer , 2014, Clinical and Translational Oncology.

[8]  B. Tian,et al.  CD146 protein as a marker to predict postoperative liver metastasis in colorectal cancer. , 2013, Cancer biotherapy & radiopharmaceuticals.

[9]  Xiyun Yan,et al.  CD146, a multi-functional molecule beyond adhesion. , 2013, Cancer letters.

[10]  G. Feng,et al.  CD146 gene expression in clear cell renal cell carcinoma: a potential marker for prediction of early recurrence after nephrectomy , 2012, International Urology and Nephrology.

[11]  Wen-fang Liu,et al.  CD146 Expression Correlates with Epithelial-Mesenchymal Transition Markers and a Poor Prognosis in Gastric Cancer , 2012, International journal of molecular sciences.

[12]  F. Tanaka,et al.  The expression of CD146 predicts a poor overall survival in patients with adenocarcinoma of the lung. , 2012, Anticancer research.

[13]  X. Miao,et al.  Identification of CD146 expression, angiogenesis, and lymphangiogenesis as progression, metastasis, and poor-prognosis related markers for gallbladder adenocarcinoma , 2012, Tumor Biology.

[14]  A. Fernando,et al.  Towards understanding the mode of action of the multifaceted cell adhesion receptor CD146. , 2009, Biochimica et biophysica acta.

[15]  F. Bertucci,et al.  CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines , 2009, Breast Cancer Research.

[16]  J. Ringe,et al.  Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells. , 2008, Blood.

[17]  M. Sydes,et al.  Practical methods for incorporating summary time-to-event data into meta-analysis , 2007, Trials.

[18]  P. Bonnier,et al.  Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype. , 2007, Human pathology.

[19]  C. Bokemeyer,et al.  Determination of Microvessel Density by Quantitative Real-time PCR in Esophageal Cancer: Correlation with Histologic Methods, Angiogenic Growth Factor Expression, and Lymph Node Metastasis , 2007, Clinical Cancer Research.

[20]  M. Gariboldi,et al.  M‐CAM expression as marker of poor prognosis in epithelial ovarian cancer , 2006, International journal of cancer.

[21]  D. Becker,et al.  The role of N-Cadherin, MCAM, and β3 integrin in melanoma progression, proliferation, migration and invasion , 2006, Cancer biology & therapy.

[22]  E. Taira,et al.  Gicerin/CD146 is involved in neurite extension of NGF‐treated PC12 cells , 2005, Journal of cellular physiology.

[23]  V. Sukhatme,et al.  Critical roles of CD146 in zebrafish vascular development , 2005, Developmental dynamics : an official publication of the American Association of Anatomists.

[24]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[25]  I. Shih,et al.  Mel-CAM (CD146) expression in parotid mucoepidermoid carcinoma. , 2003, Oral oncology.

[26]  I. Petersen,et al.  Expression of the Cell Adhesion Molecule CD146/MCAM in Non-Small Cell Lung Cancer , 2003, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

[27]  M. Amin,et al.  Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression. , 2001, Gene.

[28]  S Duval,et al.  Trim and Fill: A Simple Funnel‐Plot–Based Method of Testing and Adjusting for Publication Bias in Meta‐Analysis , 2000, Biometrics.

[29]  Naomasa Miki,et al.  Expression of gicerin, a cell adhesion molecule, in the abnormal retina in silver plumage color mutation of Japanese quail (Coturnix japonica) , 1999, Neuroscience Letters.

[30]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[31]  J. Palazzo,et al.  The cell-cell adhesion receptor Mel-CAM acts as a tumor suppressor in breast carcinoma. , 1997, The American journal of pathology.

[32]  N. Takaha,et al.  Expression of gicerin in development, oncogenesis and regeneration of the chick kidney. , 1995, Differentiation; research in biological diversity.

[33]  K. Kirsch,et al.  Genomic organization of the melanoma-associated glycoprotein MUC18: implications for the evolution of the immunoglobulin domains. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Lehmann,et al.  MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[35]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[36]  D. Moher,et al.  Nonalcoholic Fatty Liver Disease and Acute Ischemic Stroke , 2010 .

[37]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[38]  Federación de Sociedades Españolas de Oncología.  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. , 2005 .